SCP
GSK icon

Sivia Capital Partners’s GSK GSK Stock Holding History

Sivia Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$542K Sell
10,340
-1,589
-13% -$84K 0.07% 326
2026
Q1 		$658K Sell
11,929
-5,101
-30% -$276K 0.13% 210
2025
Q4 		$835K Buy
17,030
+3,845
+29% +$179K 0.17% 150
2025
Q3 		$569K Buy
13,185
+6,483
+97% +$253K 0.16% 129
2025
Q2 		$257K Buy
6,702
+24
+0.4% +$917 0.09% 332
2025
Q1 		$259K Buy
6,678
+68
+1% +$2.49K 0.12% 193
2024
Q4 		$224K Buy
6,610
+1,507
+30% +$54.3K 0.11% 159
2024
Q3 		$209K Buy
+5,103
New +$209K 0.12% 187
2024
Q2 		– Sell
-5,110
Closed -$219K – 201
2024
Q1 		$219K Buy
+5,110
New +$211K 0.15% 159

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Sivia Capital Partners's GSK Position: Q2 2026 in Review

Sivia Capital Partners reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $84K and leaving 10,340 shares worth $542K. The position accounts for 0.07% of the portfolio, ranked #326.

Sivia Capital Partners first reported a position in GSK in Q1 2024 and has held it in 9 quarters since. The position peaked at $835K in Q4 2025. 269 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sivia Capital Partners held 10,340 shares of GSK worth $542K as of Q2 2026.
  • Sivia Capital Partners sold 1,589 GSK shares in Q2 2026, an estimated $84K.
  • GSK made up 0.07% of Sivia Capital Partners's portfolio in Q2 2026, its #326 holding.
  • Sivia Capital Partners first reported a position in GSK in Q1 2024 and has held it in 9 quarters since.
  • Sivia Capital Partners's GSK position peaked at $835K in Q4 2025.
  • 269 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.